Opinion

Video

Expert Insights on Updates in Adjuvant Therapy for Muscle-Invasive Bladder Cancer

Author(s):

Elizabeth R. Plimack, MD, MS, FASCO,Neeraj Agarwal, MD

Experts on muscle-invasive bladder cancer respond to recent data in adjuvant therapy that were presented at ASCO GU 2024.

Newsletter

Stay up to date on the most recent and practice-changing oncology data

Subscribe Now!
Related Videos
Bradley McGregor, MD
Regina Barragan-Carrillo, MD
4 experts are featured in this series.
Angela Jain, MD
E. Gabriela Chiorean, MD, FASCO, clinical director, GI Medical Oncology Program, professor, Clinical Research Division, and affiliate investigator, Translational Science and Therapeutics Division Fred Hutchinson Cancer Center; professor, medicine, University of Washington; director, Clinical Research GI Oncology Program, University of Washington/Fred Hutch
Kathryn E. Beckermann, MD, PhD
Related Content
RCC | Image Credit: © Crystal light – stock.adobe.com
March 19th 2025

Fruquintinib/Sintilimab Generates Favorable PFS Outcomes in Advanced RCC

Oncology Unplugged With Dr Chandler Park
February 26th 2025

Neoadjuvant MVAC/Pembrolizumab Generates Unprecedented pCR Rates in Non-Urothelial MIBC: With Chandler Park, MD; Petros Grivas, MD, PhD; and Ruben Raychaudhuri, MD

Casdatifan in ccRCC | Image Credit: © Sebastian Kaulitzki – stock.adobe.com
March 12th 2025

Casdatifan Monotherapy Shows Early Efficacy Signals and Tolerable Safety Profile in Pretreated ccRCC

Ryan Cassaday, MD, associate professor, Clinical Research Division, Fred Hutchinson Cancer Center; associate professor, Division of Hematology and Oncology, University of Washington School of Medicine
January 23rd 2025

Blinatumomab-Based Regimens Enhance and Refine the B-ALL Treatment Paradigm: With Ryan Cassaday, MD

MT-8421 in Advanced Solid Tumors | Image Credit: © Cornflakesei – stock.adobe.com
March 11th 2025

MT-8421 Displays Acceptable Safety Profile in First-in-Human Trial for Advanced Solid Tumors

Cemiplimab Plus Chemotherapy in Advanced/Metastatic Penile Carcinoma | Image Credit: © Katsyarina – stock.adobe.com
March 11th 2025

Cemiplimab Plus Chemotherapy Yields Responses in Advanced/Metastatic Penile Carcinoma